Search

Your search keyword '"Ahle G"' showing total 194 results
Start Over Author "Ahle G"
194 results on '"Ahle G"'

2. Molecular and clinical diversity in primary central nervous system lymphoma

Author

Hernández-Verdin, I., Kirasic, E., Wienand, K., Mokhtari, K., Eimer, S., Loiseau, H., Rousseau, A., Paillassa, J., Ahle, G., Lerintiu, F., Uro-Coste, E., Oberic, L., Figarella-Branger, D., Chinot, O., Gauchotte, G., Taillandier, L., Marolleau, J.-P., Polivka, M., Adam, C., Ursu, R., Schmitt, A., Barillot, N., Nichelli, L., Lozano-Sánchez, F., Ibañez-Juliá, M.-J., Peyre, M., Mathon, B., Abada, Y., Charlotte, F., Davi, F., Stewart, C., de Reyniès, A., Choquet, S., Soussain, C., Houillier, C., Chapuy, B., Hoang-Xuan, K., and Alentorn, A.

Published
2023
Full Text
View/download PDF

9. CAR‐T CELLS RADICALLY MODIFY THE MANAGEMENT OF RELAPSED/REFRACTORY PRIMARY CEREBRAL LYMPHOMAS. REAL LIFE RESULTS OF THE FRENCH LOC NETWORK

Author

Choquet, S., primary, Soussain, C., additional, Waultier‐Rascalou, A., additional, Xuan, K. Hoang, additional, Guffroy, B., additional, Ahle, G., additional, Barrie, M., additional, Galicier, L., additional, Diblasi, R., additional, Ursu, R., additional, Houot, R., additional, Alcantara, M., additional, Salanouba, C., additional, Willems, L., additional, Gauthier, N., additional, Quoc, S. Nguyen, additional, Metz, C., additional, Uzunov, M., additional, Morel, V., additional, Weil, D. Roos, additional, Souchet, L., additional, Legarff‐Tavernier, M., additional, and Houillier, C., additional

Published
2023
Full Text
View/download PDF

12. CSF biomarkers in primary CNS lymphoma

Author

Nguyen-Them, L., primary, Alentorn, A., additional, Ahle, G., additional, Soussain, C., additional, Mathon, B., additional, Le Garff Tavernier, M., additional, Houillier, C., additional, and Hoang-Xuan, K., additional

Published
2023
Full Text
View/download PDF

18. 1673MO The GCO-002 CACOVID-19 cohort: A French nationwide multicenter study of COVID-19 infected cancer patients and consequences on cancer management

Author

Lièvre, A., primary, Turpin, A., additional, Ray-Coquard, I.L., additional, Le Malicot, K., additional, Thariat, J., additional, Ahle, G., additional, Mathieu, R., additional, Sebbagh, V., additional, Debieuvre, D., additional, Canellas, A., additional, Garcia-Larnicol, M-L., additional, Colle, R., additional, Hardy-Bessard, A-C., additional, Mansi, L., additional, Bourhis, J., additional, Gorphe, P., additional, Ursu, R., additional, IDBAIH Ahmed, A., additional, Zalcman, G., additional, and Bouche, O., additional

Published
2020
Full Text
View/download PDF

19. Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Author

Louapre, C. (Céline), Collongues, N. (Nicolas), Stankoff, B. (Bruno), Giannesini, C. (Claire), Papeix, C. (Caroline), Bensa, C. (Caroline), Deschamps, R. (Romain), Créange, A. (Alain), Wahab, A. (Abir), Pelletier, J. (Jean), Heinzlef, O. (Olivier), Labauge, P. (Pierre), Guilloton, L. (Laurent), Ahle, G. (Guido), Goudot, M. (Mathilde), Bigaut, K. (Kevin), Laplaud, D. (David-Axel), Vukusic, S. (Sandra), Lubetzki, C. (Catherine), and De Sèze, J. (Jérôme)

Subjects
Aucun
Abstract

Importance: Risk factors associated with the severity of coronavirus disease 2019 (COVID-19) in patients with multiple sclerosis (MS) are unknown. Disease-modifying therapies (DMTs) may modify the risk of developing a severe COVID-19 infection, beside identified risk factors such as age and comorbidities. Objective: To describe the clinical characteristics and outcomes in patients with MS and COVID-19 and identify factors associated with COVID-19 severity. Design, Setting, and Participants: The Covisep registry is a multicenter, retrospective, observational cohort study conducted in MS expert centers and general hospitals and with neurologists collaborating with MS expert centers and members of the Société Francophone de la Sclérose en Plaques. The study included patients with MS presenting with a confirmed or highly suspected diagnosis of COVID-19 between March 1, 2020, and May 21, 2020. Exposures: COVID-19 diagnosed with a polymerase chain reaction test on a nasopharyngeal swab, thoracic computed tomography, or typical symptoms. Main Outcomes and Measures: The main outcome was COVID-19 severity assessed on a 7-point ordinal scale (ranging from 1 [not hospitalized with no limitations on activities] to 7 [death]) with a cutoff at 3 (hospitalized and not requiring supplemental oxygen). We collected demographics, neurological history, Expanded Disability Severity Scale score (EDSS; ranging from 0 to 10, with cutoffs at 3 and 6), comorbidities, COVID-19 characteristics, and outcomes. Univariate and multivariate logistic regression models were used to estimate the association of collected variables with COVID-19 outcomes. Results: A total of 347 patients (mean [SD] age, 44.6 [12.8] years, 249 women; mean [SD] disease duration, 13.5 [10.0] years) were analyzed. Seventy-three patients (21.0%) had a COVID-19 severity score of 3 or more, and 12 patients (3.5%) died of COVID-19. The median EDSS was 2.0 (range, 0-9.5), and 284 patients (81.8%) were receiving DMT. There was a higher proportion of patients with a COVID-19 severity score of 3 or more among patients with no DMT relative to patients receiving DMTs (46.0% vs 15.5%; P

Published
2020

20. Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder

Author

Tan, A, Costi, S, Morris, LS, Van Dam, NT, Kautz, M, Whitton, AE, Friedman, AK, Collins, KA, Ahle, G, Chadha, N, Do, B, Pizzagalli, DA, Iosifescu, D, Nestler, EJ, Han, M-H, Murrough, JW, Tan, A, Costi, S, Morris, LS, Van Dam, NT, Kautz, M, Whitton, AE, Friedman, AK, Collins, KA, Ahle, G, Chadha, N, Do, B, Pizzagalli, DA, Iosifescu, D, Nestler, EJ, Han, M-H, and Murrough, JW

Abstract

Major depressive disorder (MDD) is a leading cause of disability worldwide, yet current treatment strategies remain limited in their mechanistic diversity. Recent evidence has highlighted a promising novel pharmaceutical target-the KCNQ-type potassium channel-for the treatment of depressive disorders, which may exert a therapeutic effect via functional changes within the brain reward system, including the ventral striatum. The current study assessed the effects of the KCNQ channel opener ezogabine (also known as retigabine) on reward circuitry and clinical symptoms in patients with MDD. Eighteen medication-free individuals with MDD currently in a major depressive episode were enrolled in an open-label study and received ezogabine up to 900 mg/day orally over the course of 10 weeks. Resting-state functional magnetic resonance imaging data were collected at baseline and posttreatment to examine brain reward circuitry. Reward learning was measured using a computerized probabilistic reward task. After treatment with ezogabine, subjects exhibited a significant reduction of depressive symptoms (Montgomery-Asberg Depression Rating Scale score change: -13.7 ± 9.7, p < 0.001, d = 2.08) and anhedonic symptoms (Snaith-Hamilton Pleasure Scale score change: -6.1 ± 5.3, p < 0.001, d = 1.00), which remained significant even after controlling for overall depression severity. Improvement in depression was associated with decreased functional connectivity between the ventral caudate and clusters within the mid-cingulate cortex and posterior cingulate cortex (n = 14, voxel-wise p < 0.005). In addition, a subgroup of patients tested with a probabilistic reward task (n = 9) showed increased reward learning following treatment. These findings highlight the KCNQ-type potassium channel as a promising target for future drug discovery efforts in mood disorders.

Published
2020

22. Familial occurrence of tardive dyskinesia

Author

Müller, D. J., Schulze, T. G., Knapp, M., Held, T., Krauss, H., Weber, T., Ahle, G., Maroldt, A., Alfter, D., Maier, W., Nöthen, M. M., and Rietschel, M.

Published
2001

24. P14.87 Leptomeningeal dissemination in high grade glioma: Correlation of MRI, cytology and standard CSF indices

Author

Durand, H, primary, Lamy, F, additional, Parratte, T, additional, Brinet, A, additional, Blain, A, additional, Gaultier, C, additional, Droy-Dupré, L, additional, Leblanc, S, additional, Oesterlé, H, additional, Olteanu, S, additional, Atlani, D, additional, Voirin, J, additional, Mokhtari, K, additional, and Ahle, G, additional

Published
2019
Full Text
View/download PDF

35. MANAGEMENT PATTERNS AND OUTCOME OF PATIENTS WITH PRIMARY CNS LYMPHOMA (PCNSL) IN FRANCE DURING 2011-2016. A LOC NETWORK STUDY

Author

Houillier, C., Soussain, C., Ghesquieres, H., Soubeyran, P., Chinot, O., Taillandier, L., Houot, R., Ahle, G., Gyan, E., Hoang-Xuan, K., Service de neurologie 2 [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CRLCC René Huguenin, Microenvironnement et cancer (MiCa), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], and Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)

Subjects
[SDV.CAN]Life Sciences [q-bio]/Cancer, ComputingMilieux_MISCELLANEOUS
Abstract

International audience; no abstract

Published
2016
Full Text
View/download PDF

39. Primary central nervous system lymphoma of the spinal cord: A LOC network cohort study

Author

Valyraki, N., Ahle, G., Tabouret, E., Houot, R., Jardin, F., Ghesquières, H., Schmitt, A., Paillassa, J., Choquet, S., Soussain, C., Ursu, R., Nichelli, L., Legarff-Tavernier, M., Mathon, B., Rozenblum, L., Mokhtari, K., Hoang-Xuan, K., and Houillier, C.

Abstract

Primary central nervous system lymphoma (PCNSL) mainly affects the brain (>90% cases); there are very little data pertaining to PCNSL involving the spinal cord.

Published
2024
Full Text
View/download PDF

45. P11.03 * OPTIC NERVE INFILTRATION OF PRIMARY CNS LYMPHOMA

Author

Ahle, G., primary, Hoang-Xuan, K., additional, Cassoux, N., additional, Touitou, V., additional, Soussain, C., additional, Humbrecht-Kraut, C., additional, Manoila, I., additional, Bouyon, M., additional, Schroers, R., additional, and Houillier, C., additional

Published
2014
Full Text
View/download PDF

50. MEDICAL RADIATION THERAPIES

Author

Ahmed, I., primary, Biswas, A., additional, Krishnamurthy, S., additional, Julka, P., additional, Rath, G., additional, Back, M., additional, Huang, D., additional, Gzell, C., additional, Chen, J., additional, Kastelan, M., additional, Gaur, P., additional, Wheeler, H., additional, Badiyan, S. N., additional, Robinson, C. G., additional, Simpson, J. R., additional, Tran, D. D., additional, Rich, K. M., additional, Dowling, J. L., additional, Chicoine, M. R., additional, Leuthardt, E. C., additional, Kim, A. H., additional, Huang, J., additional, Michaelsen, S. R., additional, Christensen, I. J., additional, Grunnet, K., additional, Stockhausen, M.-T., additional, Broholm, H., additional, Kosteljanetz, M., additional, Poulsen, H. S., additional, Tieu, M., additional, Lovblom, E., additional, Macnamara, M., additional, Mason, W., additional, Rodin, D., additional, Tai, E., additional, Ubhi, K., additional, Laperriere, N., additional, Millar, B.-A., additional, Menard, C., additional, Perkins, B., additional, Chung, C., additional, Clarke, J., additional, Molinaro, A., additional, Phillips, J., additional, Butowski, N., additional, Chang, S., additional, Perry, A., additional, Costello, J., additional, DeSilva, A., additional, Rabbitt, J., additional, Prados, M., additional, Cohen, A. L., additional, Anker, C., additional, Shrieve, D., additional, Hall, B., additional, Salzman, K., additional, Jensen, R., additional, Colman, H., additional, Farber, O., additional, Weinberg, U., additional, Palti, Y., additional, Fisher, B., additional, Chen, H., additional, Macdonald, D., additional, Lesser, G., additional, Coons, S., additional, Brachman, D., additional, Ryu, S., additional, Werner-Wasik, M., additional, Bahary, J.-P., additional, Chakravarti, A., additional, Mehta, M., additional, Gupta, T., additional, Nair, V., additional, Epari, S., additional, Godasastri, J., additional, Moiyadi, A., additional, Shetty, P., additional, Juvekar, S., additional, Jalali, R., additional, Herrlinger, U., additional, Schafer, N., additional, Steinbach, J., additional, Weyerbrock, A., additional, Hau, P., additional, Goldbrunner, R., additional, Kohnen, R., additional, Urbach, H., additional, Stummer, W., additional, Glas, M., additional, Houillier, C., additional, Ghesquieres, H., additional, Chabrot, C., additional, Soussain, C., additional, Ahle, G., additional, Choquet, S., additional, Faurie, P., additional, Bay, J.-O., additional, Vargaftig, J., additional, Gaultier, C., additional, Nicolas-Virelizier, E., additional, Hoang-Xuan, K., additional, Iskanderani, O., additional, Izar, F., additional, Benouaich-Amiel, A., additional, Filleron, T., additional, Moyal, E., additional, Iweha, C., additional, Jain, S., additional, Melian, E., additional, Sethi, A., additional, Albain, K., additional, Shafer, D., additional, Emami, B., additional, Kong, X.-T., additional, Green, S., additional, Filka, E., additional, Green, R., additional, Yong, W., additional, Nghiemphu, P., additional, Cloughesy, T., additional, Lai, A., additional, Mallick, S., additional, Roy, S., additional, Purkait, S., additional, Gupta, S., additional, Julka, P. K., additional, Rath, G. K., additional, Marosi, C., additional, Thaler, J., additional, Ay, C., additional, Kaider, A., additional, Reitter, E.-M., additional, Haselbock, J., additional, Preusser, M., additional, Flechl, B., additional, Zielinski, C., additional, Pabinger, I., additional, Miyatake, S.-I., additional, Furuse, M., additional, Miyata, T., additional, Yoritsune, E., additional, Kawabata, S., additional, Kuroiwa, T., additional, Muragaki, Y., additional, Maruyama, T., additional, Iseki, H., additional, Akimoto, J., additional, Ikuta, S., additional, Nitta, M., additional, Maebayashi, K., additional, Saito, T., additional, Okada, Y., additional, Kaneko, S., additional, Matsumura, A., additional, Karasawa, K., additional, Nakazato, Y., additional, Kayama, T., additional, Nabors, L. B., additional, Fink, K. L., additional, Mikkelsen, T., additional, Grujicic, D., additional, Tarnawski, R., additional, Nam, D.-H., additional, Mazurkiewicz, M., additional, Salacz, M., additional, Ashby, L., additional, Thurzo, L., additional, Zagonel, V., additional, Depenni, R., additional, Perry, J. R., additional, Henslee-Downey, J., additional, Picard, M., additional, Reardon, D. A., additional, Nambudiri, N., additional, Nayak, L., additional, LaFrankie, D., additional, Wen, P., additional, Ney, D., additional, Carlson, J., additional, Damek, D., additional, Blatchford, P., additional, Gaspar, L., additional, Kavanagh, B., additional, Waziri, A., additional, Lillehei, K., additional, Reddy, K., additional, Chen, C., additional, Rashed, I., additional, Barton, K., additional, Anderson, D., additional, Prabhu, V., additional, Rusch, R., additional, Belongia, M., additional, Maheshwari, M., additional, Firat, S., additional, Schiff, D., additional, Desjardins, A., additional, Glantz, M., additional, Chamberlain, M., additional, Shapiro, W., additional, Gopal, S., additional, Judy, K., additional, Patel, S., additional, Mahapatra, A., additional, Shan, J., additional, Gupta, D., additional, Shih, K., additional, Bacha, J. A., additional, Brown, D., additional, Garner, W. J., additional, Steino, A., additional, Schwart, R., additional, Kanekal, S., additional, Li, M., additional, Lopez, L., additional, Burris, H. A., additional, Soderberg-Naucler, C., additional, Rahbar, A., additional, Stragliotto, G., additional, Song, A. J., additional, Kumar, A. M. S., additional, Murphy, E. S., additional, Tekautz, T., additional, Suh, J. H., additional, Recinos, V., additional, Chao, S. T., additional, Spoor, J., additional, Korami, K., additional, Kloezeman, J., additional, Balvers, R., additional, Dirven, C., additional, Lamfers, M., additional, Leenstra, S., additional, Sumrall, A., additional, Haggstrom, D., additional, Crimaldi, A., additional, Symanowski, J., additional, Giglio, P., additional, Asher, A., additional, Burri, S., additional, Sunkersett, G., additional, Khatib, Z., additional, Prajapati, C. M., additional, Magalona, E. E., additional, Mariano, M., additional, Sih, I. M., additional, Torcuator, R., additional, Taal, W., additional, Oosterkamp, H., additional, Walenkamp, A., additional, Beerenpoot, L., additional, Hanse, M., additional, Buter, J., additional, Honkoop, A., additional, Boerman, D., additional, de Vos, F., additional, Jansen, R., additional, van der Berkmortel, F., additional, Brandsma, D., additional, Enting, R., additional, Kros, J., additional, Bromberg, J., additional, van Heuvel, I., additional, Smits, M., additional, van der Holt, R., additional, Vernhout, R., additional, van den Bent, M., additional, Wick, W., additional, Suarez, C., additional, Rodon, J., additional, Forsyth, P., additional, Gueorguieva, I., additional, Cleverly, A., additional, Burkholder, T., additional, Desaiah, D., additional, Lahn, M., additional, Zach, L., additional, Guez, D., additional, Last, D., additional, Daniels, D., additional, Nissim, O., additional, Grober, Y., additional, Hoffmann, C., additional, Nass, D., additional, Talianski, A., additional, Spiegelmann, R., additional, Cohen, Z., additional, and Mardor, Y., additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results